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Abstract
This paper describes the synthesis of H2O2–H2O filled poly(methyl methacrylate) (PMMA)
microcapsules as potential candidates for controlled O2 delivery. The microcapsules are prepared
by a water-in-oil solvent emulsion and evaporation method. The results of this study describe the
effect of process parameters on the characteristics of the microcapsules and on their in vitro
performance. The size of the microcapsules, as determined from scanning electron microscopy,
ranges from ~5 to 30 µm and the size distribution is narrow. The microcapsules exhibit an
internal morphology with entrapped H2O2–H2O droplets randomly distributed in the PMMA
continuous phase. In vitro release studies of 4.5 wt% H2O2 loaded microcapsules show that
~70% of the H2O2 releases in 24 hours. This corresponds to a total O2 production of ~12 cc per
gram of dry microcapsules. Shelf-life studies show that the microcapsules retain ~84 wt% of the
initially loaded H2O2 after nine months storage at 2-to-8 °C, which is an attractive feature for
clinical applications.
Keywords: Microcapsules, Controlled release, H2O2 encapsulation, O2 delivery, and topical
oxygenation
1. Introduction	
  
Oxygen is essential for cellular metabolism and organ functioning and the lack of sufficient
oxygen at the cellular level causes severe damage to cells and tissues (Tandara and Mustoe,
2004). Thus, sustained delivery of oxygen using chemical oxygen producing materials has
significant importance in advanced health care situations, such as wound healing (Rodriguez et
al., 2008; Sen, 2009) and tissue engineering (Harrison et al., 2007). H2O2 is a widely investigated
chemical oxygen producing compound, since it decomposes into water and oxygen and it carries
47 wt% O2 per unit mass. In general, the H2O2 decomposition reaction rate is slow, however
many catalysts accelerate this reaction rate, one among them is catalase which is in abundant
amounts in blood. H2O2 almost instantaneously decomposes when contacted with catalase.
Hence, the controlled release of H2O2 has the potential to be an effective method for sustained
oxygen delivery in the presence of catalase. The most effective way to control the delivery of O2
is to encapsulate H2O2 within a biocompatible polymer matrix. Figure 1 shows a schematic
diagram of the controlled oxygen production via this chemical oxygen delivery strategy. In this
envisioned application, H2O2-loaded polymeric microcapsules are administered into the colon
and H2O2 diffuses out of the microcapsules at a fixed rate and contacts catalase, which generates
O2. Although the encapsulation of a drug in a polymer matrix provides an effective method to
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control drug delivery, encapsulating aqueous solutions in a hydrocarbon-rich polymer presents
major engineering challenges (Atkin et al., 2004) addressed in this present study.	
  
	
  

	
  
Figure 1. Schematic diagram of controlled oxygen production via a chemical oxygen generation
strategy.	
  
A solvent emulsion and evaporation technique is a versatile encapsulation method that has been
used to encapsulate a variety of compounds in a different polymeric carriers (Li et al., 2008;
O'Donnell and McGinity, 1997; Rosca et al., 2004). The basic principle of an emulsion-based
encapsulation process is to create an oil/water or water/oil emulsion, depending on the type of
compound to be encapsulated, followed by solvent evaporation from the emulsion droplets,
which results in the formation of microspheres or microcapsules. Although research has been
reported on the preparation of oil-filled polymer microcapsules by various techniques (Berkland
et al., 2007; Dowding et al., 2004, 2005; Yow and Routh, 2006), there is limited research on the
preparation of water-filled polymer microcapsules (Atkin et al., 2004; Bean et al., 2012). A few
research groups have reported on the encapsulation of H2O2 in polymers (Ng et al., 2010;
Stefanescu et al., 2011), however the microcapsules synthesized in these studies have very small
amounts of encapsulated H2O2 and quantitative H2O2 release data are not presented in these
studies.
	
  
In the present study, H2O2–H2O filled poly(methyl methacrylate) (PMMA) microcapsules are
prepared by a solvent emulsion and evaporation method. PMMA is used because of its
biocompatibility and non-toxicity and is also an FDA approved polymer for many biomedical
applications, for example bone cements and dermal fillers (Lemperle et al., 1998; Nollenberger
and Albers, 2013; Vollrath et al., 2012). In this study no attempt is made to prove the
biocompatibility of the PMMA. Figure 2 shows a schematic diagram of the microencapsulation
process where an emulsion is created and the subsequent evaporation of solvent from the
droplets results in the formation of microcapsules. For this process to be effective the two
primary constituents, H2O2–H2O solution and PMMA, must dissolve in a mutual, highly volatile
solvent and the resultant single-phase solution must be immiscible with the continuous oil phase
used in the evaporation step. Acetone is chosen as the mutual solvent following the previous
work of Atkin et al. (Atkin et al., 2004). The acetone-rich phase consists of PMMA, H2O2–H2O
solution, acetonitrile, and acetone at weight ratios of 1:1:1:22, respectively. In this instance
acetonitrile serves two purposes as it minimizes both microcapsules agglomeration and
decomposition of H2O2 (Kim, 1979). Once the acetone-rich phase is emulsified into an oil phase
containing a surfactant, both acetone and acetonitrile evaporate from the emulsion droplets
causing the PMMA to vitrify and subsequently trap H2O2–H2O solution in the PMMA matrix.
This study reports the preparation and performance characteristics of H2O2-loaded poly(methyl
methacrylate) (PMMA) microcapsules as effective controlled oxygen producing materials. The
effect of different process parameters are systematically investigated to demonstrate the impact
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of these parameters on the characteristics and performance of the microcapsules. Data are
presented on the H2O2 loading, in vitro H2O2 release rate, O2 production rate, and shelf-life of
the PMMA microcapsules synthesized in this study. 	
  

	
  
Figure 2. Schematic representation of microcapsules preparation process used in the present
study.	
  
	
  
2. Materials and Methods	
  
2.1 Materials	
  
PMMA with weight average molecular weights (Mw) of 15,000, 96,000, 350,000, and 996,000
g/mol) are purchased from Sigma Aldrich, USA and used as received. Hydrogen peroxide (50
wt%) in water solution is purchased from Sigma Aldrich, USA and is concentrated to 80 wt% by
evaporating water in vacuum. Acetone, acetonitrile, hexane, hexadecane, and dichloromethane
are purchased from Fischer Scientific, USA and used as received. Croda Inc. USA generously
donated the dipolyhydroxystearate (DPHS) surfactant used in these studies and Span 80, the
other surfactant investigated in these studies, is purchased from Sigma Aldrich, USA. 	
  
	
  
2.2. Microcapsules preparation	
  
The H2O2–H2O solution with 80:20 (w/w) ratio is used in the entire study, except in section 3.3
where microcapsules are prepared using 50:50 (w/w) H2O2–H2O solution. Briefly, PMMA (4
wt%) and H2O2–H2O solution (4 wt%) are dissolved in a mixture of (22:1 w/w) acetone and
acetonitrile. This single-phase solution is emulsified (high shear homogenizer, IKA USA, model
T25 Ultra-Turrax) into mineral oil containing a surfactant. The ratio of acetone-rich phase to oilrich phase is 1:4 w/w. The acetone and acetonitrile are then evaporated by continuously stirring
the emulsion for ~18 hours. The resultant microcapsules are separated from the mineral oil-rich
phase by centrifuging (Fischer Scientific, USA, model: AccuSpinTM 400) at 3000 rpm for 15
minutes and the recovered microcapsules are washed twice with hexane. The microcapsules are
dried at room temperature in air and are stored at 2-to-8 °C until use.
	
  
2.3. Microcapsules characterization 	
  
The morphology of the microcapsules is determined using scanning electron microscopy (SEM)
(HITACHI SU-70). Dry microcapsules are spread on a sticky carbon tape glued to a one-inch
aluminum SEM stub and then a 10 nm platinum coating is applied via spun coat (Denton
Vacuum, LLC, USA, Model: Desk V TSC) onto the sample. 	
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The H2O2–H2O loading in the microcapsules is determined using Thermal Gravimetric Analysis
(TGA) (Perkin–Elmer USA, Model Pyris 1 TGA). The furnace is continuously flushed with
nitrogen gas at a flow of 3 L/hour. The microcapsules are heated at a rate of 10 °C/minute to 120
°C and held at this temperature for two hours. The microcapsules are then quickly heated to 200
°C at a heating rate of 100 °C/minute and held at this temperature for 30 minutes.	
  
	
  
H2O2 loading in the microcapsules is determined using permanganate titration (Automatic
potentiometric titration system, HANNA Instruments, HI 902C, USA). Approximately 50 mg of
microcapsules are dissolved in dichloromethane and distilled water is then added to the solution
to extract the H2O2. The recovered aqueous phase is assayed for H2O2 concentration. The
standard deviation of H2O2 concentration is ~2% as determined from three repeated titrations of
representative H2O2 solutions. 	
  
	
  
2.4. In vitro H2O2 release studies	
  
Six filter paper bags, each loaded with ~50 mg of microcapsules, are immersed in saline solution,
at 37°C, located in separate 20 mL screw-caped glass bottles. A bench top incubator, set at 120
rpm and 37°C, is used to continuously shake the bottles. At a specific time a filter bag is
removed from a given bottle and the amount of peroxide in the saline solution is determined by
permanganate titration as mentioned in section 2.3.	
  
	
  
3. Results and Discussion	
  
3.1. Effect of continuous phase	
  
Hexadecane and mineral oil are selected to study the effect of the continuous phase on the
characteristics of the microcapsules since an acetone-rich phase is immiscible with both oils.
Microcapsules are prepared using DPHS–mineral oil and using DPHS–hexadecane as the
continuous phases, keeping all other parameters constant. In both cases the concentration of
DPHS in the oil phase is 3 wt% based on the oil-phase weight. Figure 3 shows the SEM images
of the microcapsules prepared from both continuous phases. Although the maximum
microcapsule size is ~10 µm in both cases, the microcapsules created in mineral oil have a
narrow size distribution that ranges from 5 to 10 µm (Figure 3a), whereas the microcapsules
created in hexadecane have a broad size distribution that ranges from 1 to 10 µm (Figure 3b). In
the emulsification process the droplet formation step determines the size and size distribution of
the resulting microcapsules (Lam et al., 1996; Maa and Hsu, 1996). Droplets of acetone-rich
phase emulsified in a continuous oil phase undergo a disruptive stress, that causes droplet breakup, and a cohesive stress, that stabilizes the droplet. The disruptive stress depends on the flow
regime or fluid motion and the cohesive stress depends on the interfacial tension. A stable
droplet size results from the balance between disruptive and cohesive stresses (Mu et al., 2005).
The interfacial tension is expected to be equal for mineral oil or hexadecane as the continuous
phase, since both are hydrocarbons with an approximate surface tension of 28 mN/m (Jones and
Wedeven, 1971; Rolo et al., 2002). Hence, the disruptive stresses play a significant role in fixing
droplet size. Disruptive stresses depend on the flow regime that is fixed by the Reynolds number
(Re), which quantifies the importance of inertial forces relative to viscous forces. Re numbers
are calculated using equation (1)
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eq. (1)

where ρc and µc are the density and viscosity of the continuous phase, respectively, N is the
homogenization speed, and D is the impeller diameter. In a batch stirred tank reactor an Re
number less than 10,000 indicates laminar flow and a number greater than 10,000 indicates
turbulent flow. Values of the Re numbers listed in Table 1 show that the emulsification process is
in the laminar regime when mineral oil is used and the turbulent regime when hexadecane is
used. In both cases ~4 wt% H2O2 is loaded into the microcapsules, which indicates that the
continuous phase has no significant effect on H2O2 loading. Turbulent mixing occurs when
hexadecane is used and a broad microcapsules size distribution is obtained due to the fluctuations
inherent with this type of mixing. Laminar mixing occurs when mineral oil is used and a narrow
size distribution of microcapsules is obtained. Mineral oil is used as the continuous phase in all
further microcapsule preparations reported in this study.

a

Table 1. Calculated Reynolds numbers for the two continuous phases used in this study.
Viscosity
Density
Rec
(mPa•s)
(kg/m3)
Mineral oil
15.0a
890a
6127
b
Hexadecane
3.0
770b
26238
c

taken from ref. (Mu et al., 2005), b Dortmund data bank, calculated at N = 10,000 rpm and D = 0.025 m using
equation 1.

	
  
(a)

	
  
(b)

Figure 3. Scanning electron microscope images of H2O2 loaded PMMA microcaps prepared
using mineral oil (a) and hexadecane (b) as continuous phases.	
  
3.2. Effect of surfactant on the emulsion stability	
  
The surfactant plays a significant role in the stability of the emulsion (Tadros, 2006). Two
separate acetone-in-mineral oil emulsions are created using DPHS (3 wt%) and Span 80 (9 wt%).
Note that it is not possible to create a stable emulsion with a concentration below 9 wt% Span
80. Figure 4a shows the images of the two emulsions after one day and 15 days of preparation.
The emulsion created using DPHS remains stable as compared to the emulsion created using
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Span 80. Figure 4b shows a schematic diagram of the orientation of the two surfactants at the
oil/water interface. DPHS has two hydrophobic alkane tails and a bulky ethylene oxide
hydrophilic head, which makes DPHS a strong emulsion stabilizer compared to Span 80, which
has only one hydrophobic alkane tail and a small hydrophilic head (Tadros, 2006). DPHS is used
as the surfactant in all further microcapsule preparations reported in this study.

	
  

	
  

(a)
(b)
Figure 4. Emulsion stability using DHPS and Span 80 as the surfactants (a) A refers to the
mineral oil rich phase and B refers to the acetone rich phase and (b) surfactant orientation
at the oil-water interface (Anonymous, 2011). 	
  
3.3. Effect of PMMA molecular weight	
  
The effect of PMMA molecular weight (Mw) on the characteristics of the microcapsules is
investigated using four different Mw polymers under identical processing conditions. All the four
batches of microcapsules are prepared using 50:50 (w/w) H2O2–H2O solution. Table 2 lists the
characteristic microcapsules size and H2O2 loading from these experiments and Figure 5 shows
the SEM images of the microcapsules. As the Mw of PMMA increases from 15,000 g/mol to
996,000 g/mol, the maximum microcapsule size increases from 10 µm to 40 µm and it is evident
that the size distribution also increases. As the Mw of PMMA increases the viscosity of the
acetone-rich phase is expected to increase (Bueche, 1955; Kulicke and Kniewske, 1984)
resulting in large viscous stresses that resist droplet break-up and consequently result in largersize microcapsules. Yang et al. report similar results where microparticle size increases as the
molecular weight of the polymer increases (Yang et al., 2001). As noted, the microcapsule size
distribution is significantly narrower when lower molecular weight PMMS is used. All four
batches of microcapsules are made at 10,000 rpm homogenization speed and the induced shear
stresses at this speed are likely only sufficient to create homogeneous droplets when the lowest
Mw PMMA is used.
Table 2. Influence of PMMA molecular weight on the microcaps characteristics.	
  
PMMA Molecular Weight
Microcapsule sizea
H2O2 loadingb
(g/mol)
(µm)
(wt%)
15,000
2–10
2.4
96,700
5–15
4.0
350,000
5–25
4.0
996,000
5–40
7.0
a

as observed in SEM images; b determined from permanganate titration
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The data in Table 2 also show that H2O2 loading in the microcapsules increases as the Mw of
PMMA increases. The higher loading is likely due to the slower diffusion of H2O2 molecules
through the acetone-rich phase containing high Mw PMMA. These results are consistent with
literature studies reporting that drug loading increases as the molecular weight of the polymer
increases (Li et al., 2008). Hence, the Mw of PMMA can be used as a controlling factor to tailor
microcapsule size and H2O2 loading.
	
  

(a) Mw = 15,000 g/mol	
  

	
  

	
  

(b) Mw = 96,700 g/mol	
  

	
  
	
  
(c) Mw = 350,000 g/mol	
  
(d) Mw = 996,000 g/mol	
  
Figure 5. Scanning electron microscope images of H2O2–H2O loaded PMMA microcapsules
prepared in this study with four different molecular weight PMMA.
3.4. Effect of homogenization speed and homogenization time	
  
SEM images in Figure 6 show the change in microcapsules size when the homogenization speed
is increased from 10,000 to 24,000 rpm and the homogenization time is increased from 5 to 15
minutes. Three batches of microcapsules are prepared using 15,000 g/mol Mw of PMMA and
different homogenization speeds and homogenization times. When homogenizing at 24,000 rpm
the emulsion temperature rises from ~25 to ~50 °C, due to the high mechanical energy input into
the system. As a result of this temperature increase, acetone and acetonitrile evaporate quickly
from the emulsion droplets, which leads to faster formation of microcapsules. Therefore, to avoid
any process-induced differences to the microcapsules during homogenization, the temperature of
the mineral oil-rich phase is maintained at ~25°C, the same temperature used when
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homogenizing at 10,000 rpm. Figure 6a and 6b show the maximum microcapsules size is ~10
µm and size distribution are very similar when homogenizing at 10,000 and 24,000 rpm. At a
fixed homogenization speed of 24,000 rpm, increasing the homogenization time from 5 minutes
to 15 minutes (Figure 6b and 6c) has no significant effect on the size and size distribution of the
microcapsules. However, Figure 6c shows broken microcapsules are obtained likely due to the
rupture of hardened microcapsules at this elevated rpm and the longer homogenization time. For
all three conditions, the H2O2 loading is 4.3-to-4.5 wt%, indicating that the H2O2 loading is not
affected by these process parameters. These results show that low rpm rates and relatively short
processing times are sufficient to create reasonably monodisperse H2O2-loaded PMMA
microcapsules. The average microcapsule size obtained in this study is an order of magnitude
smaller than the average size of H2O2–loaded poly(lactic-co-glycolic acid) (PLGA) microspheres
reported by Ng et al (Ng et al., 2010), where the size ranges from 25 to 250 µm.
	
  

(a) rpm = 10,000 & time = 5 minutes	
  

	
  

(b) rpm = 24,000 & time = 5 minutes	
  

	
  

	
  

	
  
(c) rpm = 24,000 & time = 15 minutes	
  
	
  
Figure 6. SEM images of H2O2–H2O loaded PMMA microcapsules at different processing
conditions and with 15,000 g/mol PMMA.
3.5. Microcapsules internal morphology	
  
Figure 7a shows an example of the external morphology of typical H2O2–H2O loaded PMMA
microcapsules obtained in this study. The image in Figure 7b reveals an internal morphology
with 1-2 µm diameter H2O2–H2O droplets randomly distributed in the PMMA "continuous
phase". Since the PMMA concentration in the acetone-rich phase is near the saturation limit,
PMMA precipitates rapidly as acetone starts to evaporate from the emulsion droplets. Randomly
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dispersed H2O2–H2O droplets do not have sufficient time to coalesce and form a single core
given the high rigidity of vitrified PMMA, which has glass transition temperature is ~105°C
(Atkin et al., 2004). In a typical batch production of microcapsules, it is not unexpected that a
few microcapsules are formed in which randomly dispersed H2O2–H2O droplets coalesce into a
single H2O2–H2O core surrounded by a PMMA shell as seen in Figure 7c. However, this single
core-shell microcapsule morphology is expected to be in the minority relative to the multi-H2O2–
H2O droplet morphology shown in Figure 7b.
	
  

(a)

	
  
	
  

	
  

(b)

(c)
	
  
Figure 7. SEM images of H2O2–H2O loaded PMMA microcapsules synthesized in this study; (a)
typical microcapsule close view, (b) inside view of microcapsules with multiple H2O2–
H2O cores, and (c) a microcapsule with a single, H2O2–H2O core.
3.6. Thermal analysis of microcapsules 	
  
When TGA analysis is used to determine the amount of H2O2–H2O loading in the microcapsules
it is important to distinguish H2O2–H2O from H2O2 loading, where H2O2 loading is determined
using permanganate titration (see section 2.3). Figure 8 shows a typical H2O2–H2O weight loss
curve for microcapsules loaded with 4.5 wt% of H2O2. Figure 8a compares the H2O2–H2O
weight loss from microcapsules with that of as-received PMMA showing that ~1.4 wt% of
absorbed moisture or other volatiles are present in the as-received PMMA. The microcapsules
are loaded with 8.4 wt% of H2O2–H2O, which is obtained by subtracting the weight loss of asreceived PMMA from the total weight loss of microcapsules. Note that PMMA thermally
	
  

9

degrades at temperatures higher than 200 °C (Kandare et al., 2006) and therefore, the weight loss
up to 120 °C is only considered as H2O2–H2O loss.
Figure 8b compares the H2O2–H2O weight loss from microcapsules with that of as-received
H2O2–H2O (50:50 w/w) solution. H2O2–H2O solution evaporates within 10 minutes even before
the sample reaches 120 °C, whereas the microcapsules only lose ~20% of available H2O2–H2O
over the same time period. This observation reinforces the conclusion that H2O2–H2O solution is
predominantly encapsulated within the PMMA matrix, in agreement with the SEM micrographs
shown in Figure 7b. Once the temperature reaches 120 °C, which is slightly above the PMMA
glass transition temperature of ~105 °C, PMMA exhibits rubbery behavior and H2O2–H2O more
rapidly diffuses from the polymer. In 30 minutes the microcapsules lose ~85% of available
H2O2–H2O and the remaining 15% loss occurs in 90 minutes as the sample is held at 120 °C. The
slow diffusion of H2O2 and H2O is likely due to hydrogen bonding between each of these
compounds and the carbonyl (–C=O) groups of PMMA (Chen et al., 2005; Panarin et al., 2001).
Further evidence of the hydrogen bonding character of H2O2 is detailed in literature reports of
H2O2 forming strong hydrogen bonds with the oxygen of a siloxane, an Si-O-Si group (Żegliński
et al., 2006), and with the carbonyl oxygen of polyvinylpyrrolidone (Panarin et al., 2001).
	
  

	
  
(a)

(b)
	
  
Figure 8. Weight loss from H2O2–H2O loaded PMMA microcapsules and H2O2–H2O (50:50
w/w) solution; (a) total weight basis, (○) 4.5 wt% H2O2 loading and (◇) as received
PMMA which shows moisture loss, (b) PMMA-free basis, (○) 4.5 wt% H2O2 loading
and (◇) H2O2-H2O (50:50 w/w) solution. The heating rate is 10 °C per minute up to
120°C.	
  
3.7. Shelf-life of H2O2–H2O loaded PMMA microcapsules	
  
The loss of H2O2 from the microcapsules occurs either by decomposition or diffusion to the
microcapsule surface followed by evaporation. H2O2 is more stable at low temperatures
(Żegliński et al., 2007), therefore, the microcapsules are stored at 2-to-8°C and the shelf-life is
determined by measuring H2O2 content for periods of up to nine months. Figure 9 shows the
H2O2 loss on a PMMA-free basis during a nine month storage period. The results show that
~84% of loaded H2O2 is available after nine months of storage. The long shelf-life of these
microcapsules is an attractive feature for clinical applications.
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Figure 9. Available H2O2 in the 4.5 wt% H2O2–loaded PMMA microcapsules when stored at 2to-8°C.
	
  
3.8 in vitro H2O2 release studies
Figure 10 compares the H2O2 release rate and corresponding calculated O2 production rate from
the H2O2–H2O loaded PMMA microcapsules synthesized at 10,000 and 24,000 rpm using 15,000
g/mol PMMA. The H2O2 release profile in Figure 10a is biphasic with an initial fast release rate
up to 60 minutes followed by a slower release rate from 60 minutes to 24 hours. In the first 60
minutes the H2O2 release follows zero-order kinetics with no initial burst, which indicates that
H2O2 is encapsulated in the PMMA matrix and the release is a diffusion controlled process. The
internal morphology of a microcapsules (Figure 7b) indicates that there is a distribution of
diffusion path lengths, which results in a "time averaged" delivery of H2O2 to the solution
surrounding the microcapsules. In 24 hours, ~70% of available H2O2 releases from the
microcapsules. The O2 production in Figure 10b is calculated assuming one-half mole of O2 is
created from the decomposition of H2O2 and using the ideal gas equation at 37 °C and 1 atm. The
data in Figure 10b show that ~12 cc of cumulative O2 is produced over a 24 hour period from a
gram of dry microcapsules, regardless of the homogenization speed used to create the
microcapsules. Although not shown here, the release of H2O2 and, hence, the production of O2
are essentially identical when the homogenization time is increased from five to 15 minutes at
both 10,000 and 24,000 rpm homogenization speeds. Hence, either increasing the
homogenization speed or homogenization time does not have a significant effect on the size of
the microcapsules, the H2O2 release rate, or the O2 production rate.
H2O2–loaded PMMA microcapsules synthesized in the present study have two advantages as
compared to the previously reported H2O2–loaded PLGA microspheres (Ng et al., 2010). The
total amount of O2 produced is one to two orders of magnitude higher than the O2 production
reported by Ng et al. (Ng et al., 2010). The microcapsules of present study produce sustained O2
for 24 hours whereas the microspheres produced by Ng et al. (Ng et al., 2010) last for 4 hours.
The microcapsules synthesized in the present study are candidate materials for topical
oxygenation, needed for wound healing, given the available O2 and its release for long periods of
time. Note that the in vitro cytotoxicity and in vivo performance of the H2O2–loaded PMMA
microcapsules are not reported in this study. However, there are literature studies reporting the
application of biomaterials loaded with peroxide containing compounds which, in most cases,
utilize a catalyst to convert the peroxide to oxygen. These studies show that the H2O2 containing
materials when used in combination with the peroxide decomposition catalyst are biocompatible
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and non-toxic to cells and tissues (Camci-Unal et al., 2013; Harrison et al., 2007; Li et al., 2012;
Oh et al., 2009; Wang et al., 2010).

	
  
	
  
(a) H2O2 release
(b) O2 production
Figure 10. Performance of H2O2–H2O loaded PMMA microcapsules, at 37 °C, synthesized using
different homogenization speeds (▲) 10,000 rpm and (●) 24,000 rpm, both with 15,000
g/mol PMMA and a homogenization time of five minutes.
Figure 11 compares the H2O2 release rate and corresponding O2 production rate from the 4.5
wt% H2O2–loaded PMMA microcapsules after one day and after six months of storage at 2-to-8
°C. After six months of storage, the rate of H2O2 release in the first 60 minutes is equivalent to
that observed with freshly prepared microcapsules indicating storage time has no effect on the
H2O2 release in this initial time period. However, the 24 hour, cumulative release of H2O2 is
decreased by 10% after six months of storage. During storage, H2O2 slowly diffuses through the
PMMA continuous phase and, as a result, more hydrogen bonds can be formed between H2O2
and the carbonyl groups of PMMA. The decrease in cumulative H2O2 release is likely due to the
increase in number of H2O2–PMMA hydrogen bonds. Figure 11b shows the total O2 production
is decreased by ~20% after six months storage due to the combined effect of an ~11% storage
loss of H2O2 and a 10% lower cumulative release.
	
  

	
  

(a) H2O2 release
(b) O2 production
	
  
Figure 11. Effect of storage time on the H2O2 release rate at 37 °C from the H2O2– H2O loaded
PMMA microcapsules after one day (●) and after six months (▲) of storage at 2-to-8°C.
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4. Conclusions	
  
We have successfully synthesized H2O2–loaded PMMA microcapsules. The microcapsules size
and size distribution are independent of homogenization speed and time for a given molecular
weight PMMA. Microcapsules size and H2O2 loading increases as the molecular weight of the
PMMA increases. Controlled production of O2 is achievable with H2O2–loaded PMMA
microcapsules that can be used for systemic and topical oxygenation for a period of 24 hours. A
gram of dry microcapsules produces a total of 10-to-12 cc of O2 in 24 hours. This O2 delivery
rate is approximately one to two orders of magnitude higher than the typical skin O2
consumption (Roe et al., 2010). The H2O2–loaded PMMA microcapsules also have potential
applications as anti-microbial agents. Animal studies are in progress to asses the in vivo
performance of these microcapsules and those results will be published elsewhere. 	
  
Acknowledgment	
  
The authors gratefully acknowledge support from the Office of Naval Research from Grant
N000140710526.	
  
	
  
References	
  
Anonymous, 2011. Dipolyhydroxy stearate: Product brochure. Corda Inc., USA, pp. 1-4.
Atkin, R., Davies, P., Hardy, J., Vincent, B., 2004. Preparation of aqueous core/polymer shell
microcapsules by internal phase separation. Macromolecules 37, 7979-7985.
Bean, K., Black, C.F., Govan, N., Reynolds, P., Sambrook, M.R., 2012. Preparation of aqueous
core/silica shell microcapsules. J. Colloid Interface Sci. 366, 16-22.
Berkland, C., Pollauf, E., Varde, N., Pack, D., Kim, K., 2007. Monodisperse liquid-filled
biodegradable microcapsules. Pharm. Res. 24, 1007-1013.
Bueche, F., 1955. Viscoelasticity of poly(methacrylates). J. Appl. Phys. 26, 738-749.
Camci-Unal, G., Alemdar, N., Annabi, N., Khademhosseini, A., 2013. Oxygen Releasing
Biomaterials for Tissue Engineering. Polym Int 62, 843-848.
Chen, J.-K., Kuo, S.-W., Kao, H.-C., Chang, F.-C., 2005. Thermal properties, specific
interactions, and surface energies of PMMA terpolymers having high glass transition
temperatures and low moisture absorptions. Polymer 46, 2354-2364.
Dowding, P.J., Atkin, R., Vincent, B., Bouillot, P., 2004. Oil core/polymer shell microcapsules
prepared by internal phase separation from emulsion droplets. I: Characterization and release
rates for microcapsules with polystyrene shells. Langmuir 20, 11374-11379.
Dowding, P.J., Atkin, R., Vincent, B., Bouillot, P., 2005. Oil core/polymer shell microcapsules
by internal phase separation from emulsion droplets. II: controlling the release profile of active
molecules. Langmuir 21, 5278-5284.
Harrison, B.S., Eberli, D., Lee, S.J., Atala, A., Yoo, J.J., 2007. Oxygen producing biomaterials
for tissue regeneration. Biomaterials 28, 4628-4634.
Jones, W.R., Wedeven, L.D., 1971. Surface tension measurements in air of liquid lubricants to
200 °C by the differential maximum bubble pressure technique, National Aeronautics and Space
Administration, p. 21.
Kandare, E., Deng, H., Wang, D., Hossenlopp, J.M., 2006. Thermal stability and degradation
kinetics of poly(methyl methacrylate)/layered copper hydroxy methacrylate composites. Polym.
Adv. Technol. 17, 312-319.
	
  

13

Kim, L., 1979. Hydrogen peroxide stabilization, in: USPTO (Ed.). Shell Oil Company, Houston,
TX, USA.
Kulicke, W.M., Kniewske, R., 1984. The shear viscosity dependence on concentration,
molecular weight, and shear rate of polystyrene solutions. Rheol Acta 23, 75-83.
Lam, A., Sathyagal, A.N., Kumar, S., Ramkrishna, D., 1996. Maximum stable drop diameter in
stirred dispersions. AIChE J. 42, 1547-1552.
Lemperle, G., Gauthier-Hazan, N., Lemperle, M., 1998. PMMA-Microspheres (Artecoll) for
long-lasting correction of wrinkles: refinements and statistical results. Aesthetic plastic surgery
22, 356-365.
Li, M., Rouaud, O., Poncelet, D., 2008. Microencapsulation by solvent evaporation: State of the
art for process engineering approaches. Int. J. Pharm. 363, 26-39.
Li, Z., Guo, X., Guan, J., 2012. An oxygen release system to augment cardiac progenitor cell
survival and differentiation under hypoxic condition. Biomaterials 33, 5914-5923.
Maa, Y.-F., Hsu, C., 1996. Liquid-liquid emulsification by rotor/stator homogenization. J.
Control. Release 38, 219-228.
Mu, Y., Lyddiatt, A., Pacek, A.W., 2005. Manufacture by water/oil emulsification of porous
agarose beads: Effect of processing conditions on mean particle size, size distribution and
mechanical properties. Chem. Eng. Process. 44, 1157-1166.
Ng, S.-M., Choi, J.-Y., Han, H.-S., Huh, J.-S., Lim Jeong, O., 2010. Novel microencapsulation of
potential drugs with low molecular weight and high hydrophilicity: hydrogen peroxide as a
candidate compound. Int. J. Pharm. 384, 120-127.
Nollenberger, K., Albers, J., 2013. Poly(meth)acrylate-based coatings. Int J Pharm 457, 461-469.
O'Donnell, P.B., McGinity, J.W., 1997. Preparation of microspheres by the solvent evaporation
technique. Adv. Drug Deliv. Rev. 28, 25-42.
Oh, S.H., Ward, C.L., Atala, A., Yoo, J.J., Harrison, B.S., 2009. Oxygen generating scaffolds for
enhancing engineered tissue survival. Biomaterials 30, 757-762.
Panarin, E.F., Kalninsh, K.K., Pestov, D.V., 2001. Complexation of hydrogen peroxide with
polyvinylpyrrolidone: ab initio calculations. Eur. Polymer J. 37, 375-379.
Rodriguez, P.G., Felix, F.N., Woodley, D.T., Shim, E.K., 2008. The role of oxygen in wound
healing: A review of the literature. Dermatol. Surg. 34, 1159-1169.
Roe, D.F., Gibbins, B.L., Ladizinsky, D.A., 2010. Topical dissolved oxygen penetrates skin:
Model and method. J. Surg. Res. 159, e29-e36.
Rolo, L.I., Caço, A.I., Queimada, A.J., Marrucho, I.M., Coutinho, J.A.P., 2002. Surface tension
of heptane, decane, hexadecane, eicosane, and some of their binary mixtures. J. Chem. Eng. Data
47, 1442-1445.
Rosca, I.D., Watari, F., Uo, M., 2004. Microparticle formation and its mechanism in single and
double emulsion solvent evaporation. J. Control. Release 99, 271-280.
Sen, C.K., 2009. Wound healing essentials: Let there be oxygen. Wound Repair Regen 17, 1-18.
Stefanescu, E.A., Stefanescu, C., Negulescu, I.I., 2011. Biodegradable polymeric capsules
obtained via room temperature spray drying: preparation and characterization. J. Biomater. Appl.
25, 825-849.
Tadros, T., 2006. Principles of emulsion stabilization with special reference to polymeric
surfactants. J. Cosmet. Sci. 57, 153-169.
Tandara, A.A., Mustoe, T.A., 2004. Oxygen in wound healing—More than a nutrient. World J.
Surg. 28, 294-300.

	
  

14

Vollrath, A., Pretzel, D., Pietsch, C., Perevyazko, I., Schubert, S., Pavlov, G.M., Schubert, U.S.,
2012. Preparation, Cellular Internalization, and Biocompatibility of Highly Fluorescent PMMA
Nanoparticles. Macromol. Rapid Commun. 33, 1791-1797.
Wang, J., Zhu, Y., Bawa, H.K., Ng, G., Wu, Y., Libera, M., van der Mei, H.C., Busscher, H.J.,
Yu, X., 2010. Oxygen-Generating Nanofiber Cell Scaffolds with Antimicrobial Properties. ACS
Applied Materials & Interfaces 3, 67-73.
Yang, Y.-Y., Chung, T.-S., Ping Ng, N., 2001. Morphology, drug distribution, and in vitro
release profiles of biodegradable polymeric microspheres containing protein fabricated by
double-emulsion solvent extraction/evaporation method. Biomaterials 22, 231-241.
Yow, H.N., Routh, A.F., 2006. Formation of liquid core-polymer shell microcapsules. Soft
Matter 2, 940-949.
Żegliński, J., Cabaj, A., Strankowski, M., Czerniak, J., Haponiuk, J.T., 2007. Silica xerogel–
hydrogen peroxide composites: Their morphology, stability, and antimicrobial activity. Colloids
Surfa., B 54, 165-172.
Żegliński, J., Piotrowski, G.P., Piękoś, R., 2006. A study of interaction between hydrogen
peroxide and silica gel by FTIR spectroscopy and quantum chemistry. J. Mol. Struct. 794, 83-91.
	
  
	
  

	
  

15

